GYRE

GYRE Stock-Based Compensation

$7.82MTTM · USD

Period ending:

GYRE FY Stock-Based CompUSD
GYRE FY Stock-Based Comp2004-12-31: $0.002005-12-31: $0.002006-12-31: $0.002007-12-31: $2.75B2008-12-31: $2.07M2009-12-31: $2.45M2010-12-31: $4.94M2011-12-31: $8.51M2012-12-31: $7.85M2013-12-31: $5.22M2014-12-31: $3.47M2015-12-31: $326.00K2016-12-31: $635.00K2017-12-31: $863.00K2018-12-31: $2.61M2019-12-31: $3.20M2020-12-31: $3.63M2021-12-31: $3.41M2022-12-31: $13.37M2023-12-31: $7.28M2024-12-31: $831.00K2025-12-31: $7.16M$2.75B$0.00
2004-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

GYRE stock-based compensation history

Non-cash compensation expense paid in equity. The available annual fiscal periods series contains 22 observations from Dec 31, 2004 to Dec 31, 2025.

Gyre Therapeutics Inc Stock-Based Compensation — Annual fiscal periods (USD)
Period endingStock-Based Compensation (USD)
7,157,000
831,000
7,281,000
13,366,000
3,405,000
3,627,000
3,204,000
2,606,000
863,000
635,000
326,000
3,472,000
5,216,000
7,846,000
8,513,000
4,937,000
2,454,000
2,065,000
2,746,705,000
0
0
0

Compare stock-based compensation

All GYRE financial metrics · GYRE stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.